By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche disclosed after the close of the market on Tuesday that the US Federal Trade Commission has requested additional information related to its $5.7 billion hostile bid for Illumina.

The request was issued pursuant to the Hart-Scott-Rodino Antitrust Improvements Act and seeks more information about Roche's microarray business, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.